Company / EPS (Diluted)
Solid Biosciences Inc. EPS (Diluted) History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$25.50
FY2022
5-year range
-$25.50 / -$2.25
FY2018-FY2022
Trend
-776.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) changed -776% YoY in FY2022, a notable deviation from the 4-year average annual change of -178%.
Based on SEC 10-K filings.
-25.50 in FY2022.
Declined from $-2.25 to $-25.50 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, eps (diluted) decreased 776.3% year-over-year.
- Peak eps (diluted) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$25.50 | -776.3% |
| FY2021 | -$2.91 | -29.3% |
| FY2020 | -$2.25 | +21.9% |
| FY2019 | -$2.88 | +71.6% |
| FY2018 | -$10.14 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026